MIR5705

Across TCGA pan-cancer cohorts, MIR5705 RNA is linked to patient survival in 6 of 34 cancer types, making it the most broadly survival-associated MIR5705 data layer.

The strongest signal is observed in ovarian serous cystadenocarcinoma (OV), where higher MIR5705 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated MIR5705 expression acts as an unfavorable survival marker.

OV, ACC, and KIRC are the cancer types where MIR5705 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
OV	OS	Tertile	II,III,IV	0.300	0.691	.027	54	view →
ACC	OS	Tertile	All	0.133	0.686	.004	54	view →
KIRC	DFS	Tertile	IV	0.127	0.619	.008	36	view →
LGG	DFS	Tertile	All	0.214	0.739	<.001	36	view →
STAD	DFS	Tertile	IV	0.083	0.379	.001	18	view →
SARC	DFS	Tertile	All	0.109	0.591	.020	9	view →

Pink = unfavorable, green = favorable. Showing the 6 strongest of 6 lineages.

MIR5705–OV (OS)

Open the OV breakdown →